Advertisement

Antirhinovirus Drugs

  • D. A. J. Tyrrell
Part of the NATO ASI Series book series (NSSA, volume 73)

Abstract

Common colds are among the mildest of diseases affecting man, but they are also very frequent. Indeed, adults are said to have from 2 to 5 episodes a year on the average and certain predisposed children may have 12 attacks a year. The disease is often sufficiently severe to cause absence from work or education. In predisposed patients the colds may go on to bronchitis or may precipitate heart failure or upset the control of diabetes.

Keywords

Respiratory Syncytial Viral Infection Common Cold Respiratory Epithelium Nasal Secretion Tracheal Epithelium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    GWALTNEY, J. M. (1957) Rhinoviruses. Yale J. Biol. Med. 108, 444–453Google Scholar
  2. 2.
    LARSON, H. E,, REED, S. E., and TYRRELL, D. A. J. (1980) Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J. med. Virol., 5, 221–229Google Scholar
  3. 3.
    MACNAUGHTON, M. R. (1982) The structure and replication of rhinoviruses, Current Topics in Microbiology and Immunology 21, 1–26CrossRefGoogle Scholar
  4. 4.
    GREENBERG, S. B., HARMON, M. W., TYRRELL, D. A. J. and SCOTT, G. M. (1981–82) Trials of interferon in respiratory infections in man. Texas Rep. Biol. Med. 51, 549–553Google Scholar
  5. 5.
    HILL, D. A., BARON, S., PERKINS, J. C., WORTHINGTON, M., VAN KIRK, J. E., MILLS, J., KAPIKIAN, A. Z., CHANOCK, R. M. (1972) Evaluation of an interferon inducer in viral respiratory disease. J. Amer. Med. Assoc. 219, 1179–1184CrossRefGoogle Scholar
  6. 6.
    AOKI, F. Y., REED, S. E., CRAIG, J. W., TYRRELL, D. A. J. and LEES, L. J. (1958) Effect of a polynucleotide inducer of fungal origin on experimental rhinovirus infection in humans. J. Infect. Dis. 11, 82–86Google Scholar
  7. 7.
    DOUGLAS, R. G. and BETTS, R. F. (1974) Effect of induced interferon in experimental rhinovirus infections in volunteers. Infect. Immun. 2, 506–510Google Scholar
  8. 8.
    STANLEY, E. D., JACKSON, G. G., DIRDA, V. A. and RUBENIS, M. (1976) Effect of a topical interferon inducer on rhinovirus infections in volunteers. J. Infect. Dis. (Supp/June 1976 ) 121–127Google Scholar
  9. 9.
    ACORNLEY, J. E., BESSELL, C. J., BYNOE, M. L., GOTFREDSEN, W. O. and KNOYLE, J. M. (1967) Antiviral activity of sodium fusidate and related compounds. Brit. J. Pharmacol. Chemother. 11, 210–220CrossRefGoogle Scholar
  10. 10.
    MATHUR, A., BEARE, A. S. and REED, S. E. (1973) In vitro activity and preliminary clinical trials of a new adamantane compound. Antimicrob. Agents Chemother. 4, 421–426CrossRefPubMedGoogle Scholar
  11. 11.
    REED, S. E. and BYNOE, M. L. (1970) The antiviral activity of isoquinoline drugs for rhinoviruses in vitro and in vivo. J. med. Microbiol. 21, 346–352CrossRefGoogle Scholar
  12. 12.
    TOGO, Y., SCHWARTZ, A. R. and HORNICK, R. B. (1973) Antiviral effect of 3,4-dihydro-l-isoquinoline acetamide hydrochloride in experimental human rhinovirus infection. Chemotherapy. 18, 17CrossRefPubMedGoogle Scholar
  13. 13.
    SOTO, A. J., HALL, T. S. and REED, S. E. (1973) Trial of the antiviral action of isoprinosine against rhinovirus infection of volunteers. Antimicrobial Agents Chemother. 2, 332–334CrossRefGoogle Scholar
  14. 14.
    ANON (1982) Inosiplex: Antiviral, immunomodulator, or neither? Lancet 1, 1052–1054Google Scholar
  15. 15.
    TAMM, I., CALIGUIRI, L. A. (1972) 2-(oC-hydroxybenzyl) benzimidazole and related compounds in: Chemotherapy of virus diseases I. Ed. D. J. BAUER 115–180Google Scholar
  16. 16.
    KORANT, B. D., BAUER, J. C., BUTTERWORTH, B. E. (1974) Zinc ions inhibit replication of rhinoviruses. Nature 248, 558–560CrossRefGoogle Scholar
  17. 17.
    BEARE, A. S., and REED, S. E. (1977) The study of antiviral compounds in volunteers in: Chemoprophylaxis and virus infection of the respiratory tract. Vol II Ed J. Oxford C.R.C. Press, Cleveland, Ohio p27–55Google Scholar
  18. 18.
    PINTO, C. A., BARN SEN, H. P., RAVIN, L. J., HAFF, R. F. and PAGANO, J. E. (1972) The antiviral effect of a triazinoindole (SKand F 40491) in rhinovirus infected gibbons. Proc. Soc. exp. Biol. Med. 141, 467–74PubMedGoogle Scholar
  19. 19.
    TOGO, Y., SCHWARTZ, A. R. and HORNICK, R. B. (1973) Failure of a 3-substituted triazoinoinsole in the prevention of experimental human rhinovirus infection. Chemotherapy, 18, 17–26CrossRefPubMedGoogle Scholar
  20. 20.
    REED, S. E., CRAIG, J. W. and TYRRELL, D. A. J. (1976) Four compounds active against rhinovirus: comparison in vitro and in volunteers. J. Infect. Dis. (Suppl) 138:Al28-A135Google Scholar
  21. 21.
    DELONG, D. C. and REED, S. E. (1980) Inhibition of rhinovirus replication in organ culture by a potential antiviral drug. J. infect. Dis. 141, 87–91CrossRefPubMedGoogle Scholar
  22. 22.
    PHILLPOTTS, R. J., JONES, R. W., DELONG, D. C., REED, S. E., WALLACE, J. and TYRRELL, D. A. J. (1981) The activity of enviroxime against rhinovirus infection in man. Lancet 11, 1342–1344CrossRefGoogle Scholar
  23. 23.
    HAYDEN, F. G. and GWALTNEY, J. M. Jr (1982) Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection. Antimicrob. Agents Chemother. 21, 892–897CrossRefPubMedGoogle Scholar
  24. 24.
    LEVANDOWSKI, R. A., PACHUCKI, C. T., RUBENIS, M. and JACKSON, G. G. (1983) Topical enviroxime against rhinovirus infection. Antimicrob. Agents Chemother. 22, 1004–7CrossRefGoogle Scholar
  25. 25.
    PHILLPOTTS, R. J., WALLACE, J., TYRRELL, D. A. J. and TAGART, V. B. (1983) A study of the therapeutic activity of enviroximeagainst rhinovirus infection in volunteers. Antimicrob. Agents Chemother. 21: 671–675CrossRefGoogle Scholar
  26. 26.
    BAUER, D. J., SELWAY, J. W. T., BATCHELOR, J. F., TISDALE, MARGARET, CALDWELL, IAN C. and YOUNGS D. A. B. (1981) 4’, 6-Dichloroflavan (BW683c) a new antirhinovirus compound. Nature 222 (5821) 369–70Google Scholar
  27. 27.
    PHIT,T,P0TTS, R. J., WALLACE, J. W., TYRRELL, D. A. J., FREESTONE, D. and SHEPHERD, W. N. (1983) Failure of oral 4, 6, dichloroflavan to protect against rhinovirus infection in man. Arch. Virol., 1: 15–21Google Scholar
  28. 28.
    ITHITSUKA, H., NINOMIYA, Y. T., OHSANA, C., FIJIU, M. and SUBARA, Y. (1982) Direct and specific inactivation of rhinovirus by chalcone Ro 09–0410 Antimicrob. Agents Chemother. 22, 617–21CrossRefGoogle Scholar
  29. 29.
    PHILLPOTTS, R. J., HIGGINS, P. G., WILLMAN, J., TYRRELL, D. A. J., LENNOX-SMITH, I. (1983) Evaluation of the antirhinovirus chalcone Ro 09–0410 in volunteers. Manuscript in preparation.Google Scholar
  30. 30.
    HALL, C. B., McBRIDÉ, J. T., WALSH, E. E., BELL, D. M„ GALA, C. L., HILDRETH, S., TEN EYCK. L. G. and HALL, W. J. (1983) Aerosolized ribavirin treatment with respiratory syncytial viral infection. New Eng. J. Med. 8, 1443–1447Google Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • D. A. J. Tyrrell
    • 1
  1. 1.MRC Common Cold UnitHarvard HospitalSalisbury, WiltshireEngland

Personalised recommendations